BERTI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.145
AS - Asia 6.610
EU - Europa 5.982
SA - Sud America 453
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 113
OC - Oceania 53
Totale 22.529
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.936
HK - Hong Kong 2.765
RU - Federazione Russa 1.962
IT - Italia 1.328
SG - Singapore 1.243
CN - Cina 1.163
PL - Polonia 1.055
KR - Corea 375
IE - Irlanda 371
VN - Vietnam 349
BR - Brasile 344
SE - Svezia 342
DE - Germania 225
FI - Finlandia 168
FR - Francia 163
IN - India 160
BD - Bangladesh 148
CA - Canada 132
GB - Regno Unito 129
JO - Giordania 97
NL - Olanda 62
ID - Indonesia 61
JP - Giappone 61
AU - Australia 52
TR - Turchia 43
AR - Argentina 37
ES - Italia 37
CH - Svizzera 34
MX - Messico 34
UA - Ucraina 33
IQ - Iraq 32
ZA - Sudafrica 30
CO - Colombia 22
EC - Ecuador 19
TN - Tunisia 18
AT - Austria 17
CI - Costa d'Avorio 16
PK - Pakistan 16
NG - Nigeria 15
PH - Filippine 13
BE - Belgio 11
SA - Arabia Saudita 10
VE - Venezuela 10
CL - Cile 9
CZ - Repubblica Ceca 9
BJ - Benin 8
UZ - Uzbekistan 8
CR - Costa Rica 7
JM - Giamaica 7
KE - Kenya 7
MA - Marocco 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
IL - Israele 6
LT - Lituania 6
TW - Taiwan 6
GR - Grecia 5
HN - Honduras 5
IR - Iran 5
PS - Palestinian Territory 5
DK - Danimarca 4
EG - Egitto 4
GT - Guatemala 4
MY - Malesia 4
NI - Nicaragua 4
PE - Perù 4
RO - Romania 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
DZ - Algeria 3
KZ - Kazakistan 3
MM - Myanmar 3
PY - Paraguay 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
PA - Panama 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
Totale 22.345
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.696
Santa Clara 1.541
Ashburn 1.455
Warsaw 1.042
Singapore 937
Fairfield 640
San Jose 524
Seoul 369
Chandler 368
Dublin 367
Woodbridge 278
Hefei 266
Seattle 243
Houston 228
Cambridge 214
Beijing 204
Council Bluffs 187
Wilmington 185
Milan 182
Florence 159
Dallas 151
Altamura 134
Lawrence 130
Los Angeles 127
Ho Chi Minh City 118
Ann Arbor 113
Munich 102
Buffalo 98
New York 98
Moscow 91
Lauterbourg 86
Princeton 82
Rome 78
The Dalles 73
Hanoi 69
Helsinki 68
Mumbai 67
Boston 65
Phoenix 63
Shanghai 51
Kent 49
Tokyo 49
Jakarta 47
Melbourne 47
São Paulo 46
Boardman 44
San Diego 43
Turku 40
Orem 39
Dearborn 35
Naples 35
Toronto 35
Frankfurt am Main 34
Bologna 33
Amsterdam 31
Jacksonville 30
Medford 30
Bremen 29
Chicago 29
Paris 29
Bern 28
Guangzhou 28
Lappeenranta 28
Pune 28
London 27
Figino 24
Johannesburg 23
Atlanta 22
West Jordan 22
Denver 21
Montreal 21
Clifton 20
North Bergen 20
Turin 20
Washington 18
Brooklyn 17
Redondo Beach 17
San Francisco 17
Stockholm 17
Abidjan 16
Chennai 16
Nashville 16
Hillsboro 15
Falls Church 14
Norwalk 14
Sesto Fiorentino 14
Abuja 13
Bengaluru 13
Brasília 13
Haiphong 13
Dong Ket 12
Mexico City 12
Miano 12
Venice 12
Yubileyny 12
Brussels 11
Charlotte 11
Manchester 11
Philadelphia 11
Prato 11
Totale 15.393
Salva come PNG Salva come JPEG
Nome #
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 2.307
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 408
Bile leak after elective laparoscopic cholecystectomy: Role of MR imaging 352
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 346
Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction. 342
Fetal striatal grafting slows motor and cognitive decline of Huntington's disease 307
FDG PET and the genetics of dementia 298
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. 291
The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas 273
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 265
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 259
Amyloid Angiopathy related inflammation and paroxysmal events refractory to anti-seizure therapy: amyloid spells or seizures? 256
Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana 256
Neuroimaging studies in subjects at genetic risk of developing Alzheimer's disease: the role of neuroimaging to reveal the endophenotype 254
Typical lung carcinoids: review of classification, radiological signs and nuclear imaging findings 232
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 229
Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery 229
Metastatic intracranial solitary fibrous tumors/hemangiopericytomas: description of two cases with radically different behaviors and review of the literature 227
Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. 225
Clinical correlation of the binding potential with (123)I-FP-CIT in de novo idiopathic Parkinson's disease patients. 220
Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease 219
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 219
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 204
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 204
CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma 203
Diagnostic imaging of typical lung carcinoids: relationship between MDCT, 111In-Octreoscan and 18F-FDG-PET imaging features with Ki-67 index 203
Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT 202
Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: Numerical and patient data evaluation 201
Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques 200
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. 200
Biomarkers study in atypical dementia: proof of a diagnostic work-up 198
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 197
Laparoscopic splenectomy as quaternary cytoreduction for isolated parenchymal splenic recurrence of epitelial tubo-ovarian cancer: Report of a case and literature review 195
Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters 194
Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease. 192
99mTc-EDDA/HYNIC-TOC is a new opportunity in Neuroendocrine Tumors of the Lung (and in other malignant and benign pulmonary diseases) 192
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 191
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study 191
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. 191
PET/CT in diagnosis of dementia. 191
Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps 191
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 190
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 190
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 189
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 189
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 189
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 188
Primary Progressive Aphasia: Natural History in an Italian Cohort 188
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 186
Amyloid PET in the diagnostic workup of neurodegenerative disease 186
Characterization of functionally significant coronary artery disease by a coronary computed tomography angiography-based index: a comparison with positron emission tomography. 184
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 184
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 183
Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy 180
Detection of infarct size safety threshold for left ventricular ejection fraction impairment in acute myocardial infarction successfully treated with primary percutaneous coronary intervention. 180
Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging 180
Back to the future: the absolute quantification of cerebral metabolic rate of glucose 178
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma 177
Nutrient patterns and brain biomarkers of Alzheimer’s disease in cognitively normal individuals 177
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation 175
PET/CT in diagnosis of movement disorders. 174
Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report 173
Electronic processing of digital panoramic radiography for the detection of apical periodontitis 170
Alzheimer's disease: genetic basis and amyloid imaging as endophenotype 170
Comparing two picture naming tasks in primary progressive aphasia: Insights from behavioural and neural results 169
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 169
ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications 168
Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement 168
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults 168
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 167
Structural brain changes in normal individuals with a maternal history of Alzheimer's 166
Evaluation of age and sex-related metabolic changes in healthy subjects: An italian brain 18f-fdg pet study 166
Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors 164
Evaluation of early dementia (Mild cognitive impairment) 164
A tale of two tracers: Glucose metabolism and amyloid positron emission tomography imaging in Alzheimer's disease 164
A case of hemichorea/hemiballismus in a patient with Alzheimer’s disease and history of Sydenham’s chorea: the return of an old acquaintance? 161
Brain metabolic connectivity reconfiguration in the semantic variant of primary progressive aphasia 161
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 160
Anatomical remodelling of human striatum after neural transplantation in Huntington's disease 160
Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease 157
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 156
Molecular imaging and parkinson's disease 155
Sex differences in Alzheimer risk 154
Diagnostic and therapeutic challenges in mast cell sarcoma 153
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 153
Comprehensive qualitative characterization of linguistic performance profiles in primary progressive aphasia: a multivariate study with FDG-PET 151
Human Striatum Remodelling after Neurotransplantation in Huntington's Disease. 151
Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study 148
Sokoloff and Patlak methods for CMRGlu quantification with aortic image-derived input function: A feasibility study 148
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition 145
The role of molecular imaging in the frame of the revised dementia with Lewy body criteria 144
Applications of PET and SPECT in Patients with Autism Spectrum Disorder 141
Early detection of Alzheimer's disease with PET imaging. 138
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 137
Reliability of myocardial perfusion gated SPECT for the reproducible evaluation of resting left ventricular functional parameters in long-term follow-up. 135
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. 132
Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study 132
Brain : Normal Variations and Benign Findings in Fluorodeoxyglucose-PET/Computed Tomography Imaging 128
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities 124
Segmental quantitative myocardial perfusion with PET for the detection of significant coronary artery disease in patients with stable angina 123
Totale 21.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022601 0 0 86 50 16 28 22 52 27 38 115 167
2022/20231.779 146 371 100 137 110 301 235 79 200 15 38 47
2023/20241.024 27 82 89 31 56 115 38 369 22 74 85 36
2024/20255.243 157 525 298 935 1.304 637 97 433 176 129 235 317
2025/20269.250 723 2.962 667 592 855 269 843 344 420 524 291 760
2026/20271.094 247 259 588 0 0 0 0 0 0 0 0 0
Totale 22.529